Deloitte recently announced its plan to acquire Recombinant Capital Inc., a leading life sciences subscription database and advisory services firm based in the San Francisco Bay area. Deloitte will also acquire Recombinant's database of more than 1,500 subscribers and more than 20 years of industry data.
NOT FOR REPRINT
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.